The Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) will relocate to offices in Victoria later this month, further demonstrating a more collaborative era for life sciences in the UK.
The move builds on the ABPI’s agenda for change set out a year ago to strengthen its capacity to engage with and on behalf of key partners and its members.
For the BIA, the move represents an opportunity to enhance the UK’s competitive position in life sciences, expand collaborative relationships for our members and extend the UK bioscience community.
Nigel Gaymond, Chief Executive of the BIA, said: “The UK has exceptional strengths in life sciences. Establishing a central venue where those with an interest in life sciences can access the combined expertise of the BIA and ABPI will enable us to highlight more effectively all that the UK has to offer. We are looking forward to welcoming our members as well as visitors from around the globe, and demonstrating why the UK truly is one of the world’s leading life sciences destinations.”
Dr Richard Barker, Director General of the ABPI, said: “Since the establishment of the Office of Life Sciences, our two organisations have been working more collaboratively, and we are already seeing the benefits. Feedback from Government and other key stakeholders following the creation of LifeSciencesUK was very positive. Our organisations have been able to operate more strategically, and more effectively, by representing the life sciences sector with one voice, alongside the ABHI and BIVDA. This move strengthens a joint determination that the UK remain a great place to invest and do business in life sciences.”
The two trade bodies will remain as independent organisations with separate offices on a shared floor of the Victoria Street premises. This closer proximity will facilitate more effective joint working on cross-industry issues.